These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29056013)

  • 21. [The comparison of liver inflammation and fibrosis between chronic HBV and HCV infection].
    Wang L; Fan YX; Ding Y; Sheng QJ; Zhang C; Zhao LR; Xia TT; An ZY; Bai H; Shi HY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):419-423. PubMed ID: 28763858
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.
    Lin CW; Huang XL; Liu HL; Wang Y
    Dig Dis Sci; 2015 Dec; 60(12):3513-24. PubMed ID: 26112990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.
    Zhang Z; Pan Q; Duan XY; Liu Q; Mo GY; Rao GR; Fan JG
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1858-64. PubMed ID: 22989301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection.
    Dai YN; Xu CF; Pan HY; Chen MJ; Yu CH
    BMC Infect Dis; 2023 Sep; 23(1):637. PubMed ID: 37770837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of clinical and pathological features of chronic hepatitis B combined with metabolic-associated fatty liver disease].
    Shang MY; Chen YZ; Bao J; Tong YL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):126-132. PubMed ID: 37137826
    [No Abstract]   [Full Text] [Related]  

  • 28. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Sterling RK; King WC; Khalili M; Kleiner DE; Hinerman AS; Sulkowski M; Chung RT; Jain MK; Lisker-Melman MA; Wong DK; Ghany MG;
    Dig Dis Sci; 2022 Feb; 67(2):676-688. PubMed ID: 33559089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease.
    Liang J; Cai W; Han T; Jing L; Ma Z; Gao Y
    Medicine (Baltimore); 2016 Dec; 95(52):e5763. PubMed ID: 28033294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
    Diktas H; Karacaer Z; Özturk II; Cicek H
    Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.
    Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q
    Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.
    Hui RWH; Seto WK; Cheung KS; Mak LY; Liu KSH; Fung J; Wong DK; Lai CL; Yuen MF
    J Viral Hepat; 2018 Jan; 25(1):97-104. PubMed ID: 28772340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis.
    Thomopoulos KC; Arvaniti V; Tsamantas AC; Dimitropoulou D; Gogos CA; Siagris D; Theocharis GJ; Labropoulou-Karatza C
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):233-7. PubMed ID: 16462535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
    Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
    Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.